We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Kim Donaghue

Kim Donaghue MBBS, PhD, FRACP

Professor, The University of Sydney; Senior Staff Endocrinologist, Institute of Endocrinology & Diabetes, The Children's Hospital at Westmead, New South Wales, Australia

Dr. Donaghue is Conjoint Professor in Child and Adolescent Health at the University of Sydney and Senior Staff Endocrinologist at the Children’s Hospital at Westmead (CHW), where she was CoHead of Institute of Endocrinology and Diabetes (2010-2016); and Head of the Diabetes Service (2004 -2010).

She is immediate Past President of ISPAD (2020-2021); and was APEG President 2001-2003. She was Foundation Chair of Education for the Australasian Paediatric Endocrine Group (APEG) (2006-2010) and received the APEG Norman Wettenhall Award for Research and Innovation in 2015. She was a Senior Editor for the ISPAD Clinical Practice Consensus Guidelines (2004-09); and currently leads the UpToDate module on Cystic fibrosis-related diabetes.

She has published over 200 peer reviewed manuscripts and book chapters. Her major research focus has been the pathogenesis and intervention for diabetes complications. She serves on the Steering Committee for two international interventional studies to reduce complications: the Adolescent Type 1 Diabetes Cardiorenal Protection Trial (ADDIT), and the FAME-1 Eye Trial. She is currently leading a data linkage project on adult outcomes of childhood-onset diabetes.

Recent Contributions to PracticeUpdate:

  1. Continuous Glucose Monitoring and HbA1c in Cystic Fibrosis